title: Reply to 'Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''.
authors.affiliation: Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.|Department of Epidemiology and Biostatistics, Imperial College London, London W2 1PG, UK.
authors.forename: Yunxia
authors.initials: Y
authors.lastname: Lu
authors.affiliation: Centro Español de Investigación Farmacoepidemiológica, Madrid 28004, Spain.
authors.forename: Luis Alberto García
authors.initials: LA
authors.lastname: Rodríguez
authors.affiliation: Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 171 77, Sweden.
authors.forename: Linnéa
authors.initials: L
authors.lastname: Malgerud
authors.affiliation: Centro Español de Investigación Farmacoepidemiológica, Madrid 28004, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: González-Pérez
authors.affiliation: Centro Español de Investigación Farmacoepidemiológica, Madrid 28004, Spain.
authors.forename: Mar
authors.initials: M
authors.lastname: Martín-Pérez
authors.affiliation: Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.|King's College London, Division of Cancer Studies, London WC2R 2LS, UK.
authors.forename: Jesper
authors.initials: J
authors.lastname: Lagergren
authors.affiliation: Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.|Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden.
authors.forename: Tomas S
authors.initials: TS
authors.lastname: Bexelius
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents; D010190:Pancreatic Neoplasms; D012306:Risk
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents